(Q41355406)

29 September 2017

1 reference

title

Structural features and biochemical properties of TNF-alpha converting enzyme (TACE). (English)

1 reference

29 September 2017

M L Moss

1

1 reference

29 September 2017

S L Jin

2

1 reference

29 September 2017

J D Becherer

3

1 reference

29 September 2017

D M Bickett

4

1 reference

29 September 2017

W Burkhart

5

1 reference

29 September 2017

W J Chen

6

1 reference

29 September 2017

D Hassler

7

1 reference

29 September 2017

M T Leesnitzer

8

1 reference

29 September 2017

G McGeehan

9

1 reference

29 September 2017

M Milla

10

1 reference

29 September 2017

M Moyer

11

1 reference

29 September 2017

W Rocque

12

1 reference

29 September 2017

T Seaton

13

1 reference

29 September 2017

F Schoenen

14

1 reference

29 September 2017

J Warner

15

1 reference

29 September 2017

D Willard

16

1 reference

29 September 2017

publication date

1 February 1997

1 reference

Journal of Neuroimmunology

29 September 2017

published in

1 reference

29 September 2017

volume

72

1 reference

29 September 2017

issue

2

1 reference

29 September 2017

page(s)

127-129

1 reference

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900180-4

7 January 2021

Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900180-4

7 January 2021

Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900180-4

7 January 2021

Metalloproteinases and their inhibitors in matrix remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900180-4

7 January 2021

Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900180-4

7 January 2021

A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900180-4

7 January 2021

Matrix metalloproteinases and endometrial remodelling

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900180-4

7 January 2021

Anti?tumor necrosis factor therapy abrogates autoimmune demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900180-4

7 January 2021

Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900180-4

7 January 2021

Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900180-4

7 January 2021

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900180-4

7 January 2021

10.1016/S0165-5728(96)00180-4

Identifiers

DOI

1 reference

29 September 2017

1 reference